Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
News
TYPE
HEADLINE
FILED AT
8-K
Anixa Biosciences, Inc. Announces Results of 2026 Annual Meeting of Stockholders
8-K
Anixa Biosciences Reports Patient Survival Data from Ovarian Cancer CAR-T Trial and Secures Dose Escalation Approval
8-K
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; 74% Immune Response and All Primary Endpoints Met; Plans Phase 2 Ne
8-K
Form 8-K - Current report - Item 5.07 Item 7.01 Item 9.01
8-K
Breast Cancer Vaccine Phase 1 Trial Shows Positive Results; Phase 2 Study Planned for 2025
8-K
Biotech Firm Expands Cancer Vaccine Development Partnership with Cleveland Clinic to Target Additional Cancer Types
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
S-3
September 2025 SHELF & ATM | Float: 31,168,491
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
